Search Results Search Sort by RelevanceMost Recent Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133. Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 1 Brintha Krishnamoorthy Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403. Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 2 Kevin O'Rourke, OP Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403.
Case and Commentary Dec 2018 When Should Iatrogenic Polypharmacy Be Considered a Disease? Christine Wieseler, PhD When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical. AMA J Ethics. 2018;20(12):E1133-1138. doi: 10.1001/amajethics.2018.1133.
Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 1 Brintha Krishnamoorthy Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403.
Case and Commentary Mar 2004 Disagreement over Error Disclosure, Commentary 2 Kevin O'Rourke, OP Virtual Mentor. 2004;6(3):103-107. doi: 10.1001/virtualmentor.2004.6.3.ccas1-0403.